10^th Annual Heart Rhythm Conference

About the Conference

The 10th Annual Heart Rhythm Conference 2027 will be hosted by the conference organizers and is scheduled to take place on May 13–14, 2027, in Rome, Italy. Centered on the theme “Advancing Heart Rhythm Care: Innovation, Technology & Better Outcomes,” the conference aims to highlight critical developments in cardiac electrophysiology, arrhythmia management, cardiovascular research, and innovative approaches to heart rhythm care.

The primary objective of the Heart Rhythm Conference 2027 is to provide a dynamic global platform for cardiologists, electrophysiologists, cardiac surgeons, researchers, academicians, and other healthcare professionals to engage in meaningful scientific discussions and exchange innovative ideas. The conference program will feature keynote lectures, oral and poster presentations, scientific sessions, symposiums, workshops, and networking opportunities, focusing on the latest advances in cardiac arrhythmias, catheter ablation, pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy, and emerging technologies in rhythm monitoring and management.

Why to Attend?

The 10th Annual Heart Rhythm Conference 2027 offers an international forum for scientific learning and professional collaboration, bringing together leading clinicians, researchers, healthcare professionals, and industry representatives to share expertise and explore innovations in cardiovascular medicine. The scientific program is designed to encourage discussions on current clinical practices, emerging technologies, research findings, and evolving approaches to the diagnosis and treatment of heart rhythm disorders.

The conference provides opportunities to participate as a delegate, invited or keynote speaker, oral presenter, poster presenter, or panel participant, subject to the available program and selection process. Attendees can exchange clinical experiences, present research findings, explore new developments in electrophysiology, and establish professional connections with colleagues from around the world. The event also offers opportunities for sponsors and exhibitors to showcase relevant medical technologies, devices, products, and services, supporting professional development, scientific exchange, and potential research collaborations in heart rhythm care.

Target Audience

1. Cardiologists and Clinical Cardiologists
2. Cardiac Electrophysiologists and Arrhythmia Specialists
3. Cardiothoracic and Cardiovascular Surgeons
4. Interventional Cardiologists
5. Heart Rhythm Researchers and Scientists
6. Cardiovascular Physicians and Clinical Practitioners
7. Cardiac Nurses and Cardiovascular Care Professionals
8. Electrophysiology Laboratory Technologists
9. Cardiac Device Specialists and Implanting Physicians
10. Researchers in Cardiac Electrophysiology and Cardiovascular Physiology
11. Biomedical Engineers and Medical Device Developers
12. Specialists in Pacemakers, ICDs, and Cardiac Resynchronization Therapy
13. Cardiac Imaging and Diagnostic Professionals
14. Academicians, Professors, and Medical Educators
15. Postdoctoral Researchers, Medical Fellows, and Graduate Students
16. Clinical Trial Coordinators and Clinical Research Associates
17. Pharmaceutical and Biotechnology Professionals
18. Digital Health, Remote Monitoring, and Medical Technology Specialists
19. Healthcare Administrators and Cardiovascular Program Directors
20. Medical Device Manufacturers, Industry Representatives, and Healthcare Innovators

Scientific Tracks and Sessions

Track 1: Cardiac Arrhythmias and Electrophysiology

Cardiac arrhythmias and electrophysiology focus on the mechanisms, diagnosis, and management of abnormal heart rhythms. This track explores electrical disturbances affecting cardiac function, clinical electrophysiological studies, and advanced rhythm-management strategies. Discussions highlight emerging diagnostic technologies, evidence-based treatments, and personalized approaches to improve patient outcomes and reduce arrhythmia-related complications.

• Atrial and Ventricular Arrhythmias
• Electrophysiological Mapping and Studies
• Cardiac Conduction Abnormalities

Focus Areas: Atrial Arrhythmias | Ventricular Arrhythmias | Clinical Electrophysiology | Cardiac Conduction Disorders | Electrophysiological Studies | Supraventricular Tachycardia | Premature Ventricular Contractions | Arrhythmia Mechanisms | Cardiac Electrical Remodeling | Electrophysiological Mapping | Rhythm Disturbances | Arrhythmia Risk Stratification | Advanced Rhythm Management | Personalized Arrhythmia Care | Clinical Arrhythmia Diagnosis

Track 2: Atrial Fibrillation and Atrial Flutter

Atrial fibrillation and atrial flutter are common rhythm disorders associated with stroke, heart failure, and reduced quality of life. This track explores diagnostic approaches, rate and rhythm control, anticoagulation strategies, and catheter-based interventions. Discussions highlight advances in ablation, long-term monitoring, and individualized treatment planning to improve rhythm control and prevent complications.

• Paroxysmal and Persistent Atrial Fibrillation
• Pulmonary Vein Isolation and Ablation Techniques
• Stroke Risk Assessment and Prevention

Focus Areas: Atrial Fibrillation | Atrial Flutter | Paroxysmal Atrial Fibrillation | Persistent Atrial Fibrillation | Rate Control | Rhythm Control | Stroke Prevention | Anticoagulation Strategies | Catheter Ablation | Pulmonary Vein Isolation | Atrial Substrate Modification | AF Recurrence Prevention | Left Atrial Appendage Closure | Post-Ablation Monitoring | Long-Term Rhythm Management

Track 3: Ventricular Arrhythmias and Sudden Cardiac Death

Ventricular arrhythmias, including ventricular tachycardia and ventricular fibrillation, can cause life-threatening hemodynamic instability and sudden cardiac death. This track examines risk stratification, emergency management, preventive interventions, and advanced treatment options. Developments in catheter ablation, implantable defibrillators, and genetic risk assessment support improved identification and management of high-risk patients.

• Sustained and Nonsustained Ventricular Tachycardia
• Ventricular Fibrillation Management
• Sudden Cardiac Death Risk Prediction

Focus Areas: Ventricular Tachycardia | Ventricular Fibrillation | Sudden Cardiac Death | Risk Stratification | Implantable Cardioverter-Defibrillators | Ventricular Ablation | Inherited Arrhythmia Risk | Cardiac Arrest Prevention | Antiarrhythmic Therapy | High-Risk Patient Management | Electrical Storm Management | Scar-Related Ventricular Tachycardia | Defibrillator Programming | Cardiomyopathy-Associated Arrhythmias | Post-Resuscitation Risk Assessment

Track 4: Catheter Ablation and Interventional Electrophysiology

Catheter ablation is an established intervention for treating several cardiac rhythm disorders. This track covers modern ablation technologies, procedural planning, electroanatomical mapping, and strategies for complex arrhythmias. Discussions highlight radiofrequency ablation, cryoablation, and pulsed field ablation, with an emphasis on procedural safety, effectiveness, and long-term outcomes.

• Radiofrequency, Cryoablation, and Pulsed Field Ablation
• Three-Dimensional Mapping and Complex Arrhythmia Ablation
• Procedural Complications and Outcome Assessment

Focus Areas: Radiofrequency Ablation | Cryoballoon Ablation | Pulsed Field Ablation | Electroanatomical Mapping | Three-Dimensional Mapping | Pulmonary Vein Isolation | Complex Arrhythmia Ablation | Zero-Fluoroscopy Techniques | Procedural Safety | Post-Ablation Follow-Up | Contact Force-Sensing Catheters | Intracardiac Echocardiography | Substrate-Based Ablation | Ventricular Tachycardia Ablation | Ablation Outcome Assessment

Track 5: Cardiac Implantable Electronic Devices

Cardiac implantable electronic devices are important for treating selected bradyarrhythmias, preventing sudden cardiac death, and improving cardiac function in appropriate patients with heart failure. This track explores pacemakers, implantable cardioverter-defibrillators, and cardiac resynchronization therapy. Innovations in leadless devices, remote monitoring, and device programming are expanding therapeutic options and improving long-term patient care.

• Conventional and Leadless Pacemaker Technologies
• ICD and Cardiac Resynchronization Therapy
• Remote Monitoring and Device Troubleshooting

Focus Areas: Permanent Pacemakers | Implantable Cardioverter-Defibrillators | Cardiac Resynchronization Therapy | Leadless Pacemakers | Subcutaneous ICDs | Device Programming | Remote Device Monitoring | Device-Related Complications | Conduction System Pacing | Long-Term Device Management | Wearable Cardioverter-Defibrillators | Implantable Loop Recorders | Lead Extraction | Device Infection Prevention | Battery Longevity and Optimization

Track 6: Bradycardia and Cardiac Conduction Disorders

Bradycardia and conduction disorders involve abnormalities in the formation or transmission of electrical impulses through the heart. This track examines sinus node dysfunction, atrioventricular block, bundle branch block, and related clinical conditions. Discussions focus on diagnostic evaluation, pacing indications, and contemporary treatment strategies to prevent symptoms, improve cardiac performance, and reduce complications.

• Sinus Node Dysfunction and Sick Sinus Syndrome
• Atrioventricular Block and Intraventricular Conduction Defects
• Permanent Pacing and Physiological Pacing Strategies

Focus Areas: Sinus Node Dysfunction | Atrioventricular Block | Bundle Branch Block | Sinus Bradycardia | Conduction System Disease | Syncope Evaluation | Permanent Pacing | His-Bundle Pacing | Left Bundle Branch Area Pacing | Clinical Risk Assessment | Sick Sinus Syndrome | Fascicular Blocks | Chronotropic Incompetence | Advanced AV Conduction Disorders | Pacing Indications and Guidelines

Track 7: Inherited Arrhythmia Syndromes and Cardiac Genetics

Inherited arrhythmia syndromes can predispose individuals to serious cardiac rhythm disturbances, even in the absence of structural heart disease. This track explores genetic mechanisms, family screening, diagnostic testing, and preventive care. Emerging developments in molecular diagnostics and precision medicine support improved risk prediction and individualized management for patients with inherited electrical disorders.

• Diagnosis and Management of Inherited Arrhythmia Syndromes
• Genetic Testing, Counseling, and Family Screening
• Personalized Risk Assessment and Sudden Death Prevention

Focus Areas: Long QT Syndrome | Brugada Syndrome | Catecholaminergic Polymorphic Ventricular Tachycardia | Short QT Syndrome | Genetic Testing | Molecular Cardiology | Familial Arrhythmia Screening | Inherited Cardiomyopathies | Genetic Counseling | Sudden Death Risk Assessment | Arrhythmogenic Right Ventricular Cardiomyopathy | Genetic Variants and Phenotypes | Family Cascade Screening | Genotype-Guided Treatment | Precision Cardiac Medicine

Track 8: Wearable Technology and Remote Rhythm Monitoring

Wearable technologies and remote monitoring systems are transforming the detection and management of cardiac arrhythmias. This track focuses on smartwatches, portable electrocardiograms, mobile cardiac telemetry, and implantable loop recorders. Continuous monitoring and automated rhythm analysis support earlier detection of intermittent arrhythmias, improved follow-up, and more accessible patient-centered cardiac care.

• Wearable ECG Devices and Smartwatch-Based Arrhythmia Detection
• Holter Monitoring, Mobile Telemetry, and Implantable Loop Recorders
• Remote Patient Monitoring and Digital Follow-Up

Focus Areas: Wearable ECG Devices | Smartwatch-Based Rhythm Detection | Mobile Cardiac Telemetry | Implantable Loop Recorders | Continuous Rhythm Monitoring | Remote Patient Follow-Up | Digital Cardiology | Ambulatory ECG | Arrhythmia Alerts | Home-Based Cardiac Monitoring | Patch-Based ECG Systems | Smartphone-Connected ECG | Remote Pacemaker Monitoring | Artificial Intelligence in Wearables | Digital Health Data Integration

Track 9: Artificial Intelligence and Digital Innovation in Cardiac Rhythm Management

Artificial intelligence and digital health tools are creating new possibilities for arrhythmia detection, prediction, and treatment planning. This track explores machine learning algorithms, automated ECG interpretation, predictive analytics, and AI-assisted cardiac imaging. Emerging applications aim to improve diagnostic accuracy, identify patients at risk of serious rhythm disorders, and support personalized clinical decision-making.

• Artificial Intelligence in ECG Interpretation and Rhythm Detection
• Machine Learning for Arrhythmia Prediction and Risk Assessment
• Digital Health, Clinical Decision Support, and Data Analytics

Focus Areas: AI-Based ECG Analysis | Machine Learning | Arrhythmia Prediction | Digital Cardiology | Predictive Risk Modeling | Automated Rhythm Classification | AI-Assisted Cardiac Imaging | Clinical Decision Support | Big Data Analytics | Digital Health Innovation | Deep Learning in ECG Interpretation | Wearable Signal Analysis | Automated Atrial Fibrillation Detection | Personalized Arrhythmia Prediction | Clinical Algorithm Validation

Track 10: Electrocardiography and Advanced Cardiac Diagnostics

Electrocardiography is fundamental to the diagnosis and assessment of cardiac rhythm abnormalities. This track covers standard ECG interpretation, ambulatory ECG monitoring, exercise testing, signal analysis, and advanced diagnostic techniques. Emerging technologies in automated interpretation, high-resolution electrocardiography, and multimodal cardiac assessment are improving diagnostic precision and supporting timely clinical intervention.

• Advanced ECG Interpretation and Signal Analysis
• Holter Monitoring, Event Recorders, and Exercise Testing
• Emerging Diagnostic Technologies for Arrhythmia Detection

Focus Areas: Twelve-Lead ECG | Holter Monitoring | Exercise ECG Testing | Signal Processing | High-Resolution ECG | Ambulatory Monitoring | Event Recorders | Electrocardiographic Biomarkers | Automated ECG Interpretation | Advanced Arrhythmia Diagnostics | Signal-Averaged ECG | Heart Rate Variability | QT Interval Analysis | Electrocardiographic Imaging | Cardiac Rhythm Pattern Recognition

Track 11: Syncope, Palpitations, and Unexplained Loss of Consciousness

Syncope, palpitations, and unexplained episodes of loss of consciousness may indicate underlying cardiac rhythm disorders or other cardiovascular conditions. This track explores clinical assessment, differential diagnosis, risk stratification, and rhythm-monitoring strategies. Discussions highlight electrophysiological testing, tilt-table testing, and implantable monitoring in identifying underlying causes and preventing recurrent episodes.

• Diagnostic Evaluation of Syncope and Palpitations
• Reflex Syncope, Orthostatic Hypotension, and Cardiac Causes
• Advanced Monitoring and Prevention of Recurrent Episodes

Focus Areas: Syncope Risk Assessment | Palpitation Evaluation | Reflex Syncope | Orthostatic Hypotension | Cardiac Syncope | Ambulatory Rhythm Monitoring | Tilt-Table Testing | Electrophysiological Testing | Implantable Loop Recorders | Recurrent Syncope Prevention | Vasovagal Syncope | Arrhythmia-Related Loss of Consciousness | Autonomic Dysfunction | Emergency Syncope Evaluation | Clinical Risk Stratification

Track 12: Arrhythmias in Heart Failure and Cardiomyopathies

Heart failure and cardiomyopathies are frequently associated with electrical instability and increased risks of atrial and ventricular arrhythmias. This track examines the relationship between structural heart disease and rhythm disorders, including arrhythmia prevention, device therapy, and catheter ablation. Integrated treatment strategies aim to improve cardiac function, reduce hospitalization, and lower sudden cardiac death risk.

• Arrhythmia Management in Heart Failure and Cardiomyopathies
• Device-Based Therapies and Cardiac Resynchronization
• Ventricular Arrhythmia Prevention and Sudden Death Risk Assessment

Focus Areas: Arrhythmias in Heart Failure | Dilated Cardiomyopathy | Hypertrophic Cardiomyopathy | Arrhythmogenic Cardiomyopathy | Cardiac Resynchronization Therapy | Ventricular Arrhythmias | Sudden Death Risk Reduction | Heart Failure Devices | Catheter Ablation | Integrated Cardiac Care | Ischemic Cardiomyopathy | Nonischemic Cardiomyopathy | Atrial Fibrillation in Heart Failure | Cardiac Remodeling and Electrical Instability | Risk-Based Device Therapy

Track 13: Cardiac Pacing and Conduction System Pacing

Cardiac pacing has evolved toward physiological approaches that seek to preserve coordinated ventricular activation. This track covers conventional pacing, His-bundle pacing, left bundle branch area pacing, and leadless technologies. Discussions focus on patient selection, implantation techniques, device programming, and clinical outcomes to improve pacing effectiveness and reduce complications associated with long-term right ventricular pacing.

• His-Bundle and Left Bundle Branch Area Pacing
• Leadless Pacemakers and Advanced Implantation Techniques
• Physiological Pacing, Device Programming, and Complication Prevention

Focus Areas: Conventional Cardiac Pacing | His-Bundle Pacing | Left Bundle Branch Area Pacing | Physiological Pacing | Leadless Pacemakers | Pacing-Induced Cardiomyopathy | Device Implantation | Pacemaker Programming | Conduction System Capture | Long-Term Pacing Outcomes | Biventricular Pacing | Single-Chamber and Dual-Chamber Pacing | Pacing Threshold Optimization | Pacing-Induced Dyssynchrony | Advanced Pacing Techniques

Track 14: Anticoagulation and Thromboembolic Risk in Arrhythmias

Thromboembolic risk is an important concern in patients with atrial fibrillation and selected other cardiac conditions. This track examines stroke-risk assessment, oral anticoagulation, bleeding-risk evaluation, periprocedural management, and left atrial appendage closure. Emerging evidence and individualized treatment approaches aim to balance stroke prevention with bleeding risks and improve the safety of long-term anticoagulation.

• Anticoagulation Strategies in Atrial Fibrillation
• Stroke Prevention and Left Atrial Appendage Closure
• Bleeding Risk, Periprocedural Management, and Treatment Safety

Focus Areas: Stroke Risk Assessment | Direct Oral Anticoagulants | Warfarin Management | Thromboembolism Prevention | Bleeding Risk Assessment | Left Atrial Appendage Closure | Periprocedural Anticoagulation | Anticoagulation Safety | Individualized Stroke Prevention | Long-Term Clinical Monitoring | CHA?DS?-VASc Risk Assessment | HAS-BLED Assessment | Anticoagulation After Ablation | Management of Anticoagulant-Related Bleeding | Thromboembolic Risk in Atrial Fibrillation

Track 15: Pediatric and Congenital Heart Rhythm Disorders

Pediatric and congenital heart rhythm disorders require specialized evaluation and treatment based on age, cardiac anatomy, and developmental needs. This track explores supraventricular tachycardia, inherited arrhythmias, postoperative rhythm disturbances, and arrhythmias associated with congenital heart disease. Advances in pediatric electrophysiology, ablation, genetic evaluation, and device therapy support improved outcomes across childhood and adolescence.

• Diagnosis and Treatment of Pediatric Arrhythmias
• Congenital Heart Disease and Postoperative Rhythm Disorders
• Pediatric Ablation, Device Therapy, and Inherited Arrhythmia Care

Focus Areas: Pediatric Supraventricular Tachycardia | Congenital Heart Disease-Associated Arrhythmias | Pediatric Ablation | Inherited Rhythm Disorders | Fetal Arrhythmias | Pediatric Pacemakers | Childhood Syncope | Genetic Evaluation | Postoperative Arrhythmias | Transition to Adult Cardiac Care | Neonatal Arrhythmias | Congenital Complete Heart Block | Pediatric Ventricular Arrhythmias | Device Therapy in Children | Long-Term Follow-Up of Congenital Arrhythmias

Track 16: Arrhythmias in Pregnancy and Women's Cardiovascular Health

Arrhythmias during pregnancy and across different stages of women's lives require careful assessment of maternal health, fetal safety, and treatment-related risks. This track explores pregnancy-associated tachycardia, atrial fibrillation, inherited rhythm disorders, and arrhythmias associated with hormonal transitions. Multidisciplinary approaches involving cardiology, electrophysiology, and obstetric teams support individualized management and improved maternal cardiovascular outcomes.

• Diagnosis and Management of Arrhythmias During Pregnancy
• Medication Safety, Maternal Monitoring, and Fetal Considerations
• Inherited Arrhythmias and Postpartum Cardiovascular Care

Focus Areas: Arrhythmias During Pregnancy | Maternal Cardiac Monitoring | Medication Safety | Fetal Arrhythmias | Hormonal Influences on Heart Rhythm | Postpartum Arrhythmia Care | Inherited Arrhythmia Syndromes | Pregnancy-Related Tachycardia | Maternal Cardiovascular Risk | Multidisciplinary Cardiac Care | Supraventricular Tachycardia in Pregnancy | Atrial Fibrillation in Pregnancy | Antiarrhythmic Drug Safety | Arrhythmias During Menopause | Cardiovascular Risk Across Women's Life Stages

Track 17: Pharmacological Management of Cardiac Arrhythmias

Pharmacological management remains an important component of treating cardiac rhythm disorders, either independently or alongside catheter ablation and device-based interventions. This track examines antiarrhythmic medications, rate-control therapies, drug interactions, adverse effects, and individualized treatment selection. Discussions emphasize medication safety, proarrhythmic risk, and evidence-based strategies to improve rhythm control and long-term outcomes.

• Antiarrhythmic Drugs and Individualized Treatment Selection
• Rate and Rhythm Control in Supraventricular and Ventricular Arrhythmias
• Drug Safety, Interactions, and Proarrhythmia Prevention

Focus Areas: Antiarrhythmic Drug Therapy | Rate-Control Medications | Rhythm-Control Strategies | Sodium Channel Blockers | Potassium Channel Blockers | Beta-Blockers | Calcium Channel Blockers | Drug Interactions | Proarrhythmia Prevention | Pharmacological Treatment Monitoring | Amiodarone Therapy | Sotalol and Dofetilide | QT Prolongation | Drug-Induced Arrhythmias | Personalized Pharmacotherapy

Track 18: Emergency Cardiac Arrhythmias and Resuscitation

Acute cardiac arrhythmias can rapidly compromise circulation and require prompt recognition and intervention. This track explores cardiopulmonary resuscitation, defibrillation, synchronized cardioversion, and advanced cardiac life support. Innovations in automated external defibrillators, emergency response systems, and post-resuscitation care aim to improve survival and reduce neurological injury.

• Emergency Recognition and Management of Life-Threatening Arrhythmias
• Cardiopulmonary Resuscitation, Defibrillation, and Cardioversion
• Advanced Cardiac Life Support and Post-Resuscitation Care

Focus Areas: Cardiac Arrest Management | Cardiopulmonary Resuscitation | Defibrillation | Synchronized Cardioversion | Advanced Cardiac Life Support | Emergency Arrhythmia Recognition | Ventricular Fibrillation | Pulseless Ventricular Tachycardia | Post-Resuscitation Care | Emergency Response Systems | Automated External Defibrillators | Hemodynamically Unstable Arrhythmias | Electrical Storm Emergencies | Emergency Bradycardia Management | Neurological Outcomes After Cardiac Arrest

Track 19: Electrophysiology Laboratory Innovations and Procedural Safety

Modern electrophysiology laboratories integrate advanced mapping, imaging, navigation, and monitoring technologies to improve the diagnosis and treatment of cardiac rhythm disorders. This track addresses laboratory innovations, procedural planning, radiation reduction, anesthesia and sedation, infection prevention, and complication management. Emerging techniques and standardized safety protocols aim to improve procedural efficiency, patient outcomes, and quality assurance.

• Advanced Mapping, Imaging, and Navigation Technologies
• Radiation Reduction, Sedation, and Procedural Safety
• Quality Improvement and Management of Electrophysiology Complications

Focus Areas: Electrophysiology Laboratory Technology | Three-Dimensional Mapping | Intracardiac Echocardiography | Radiation Minimization | Procedural Sedation | Infection Prevention | Vascular Access Safety | Complication Management | Laboratory Workflow Optimization | Quality Assurance | Robotic Navigation | Remote Magnetic Navigation | Fluoroscopy-Free Ablation | Periprocedural Anticoagulation | Electrophysiology Team Training

Track 20: Clinical Trials, Precision Medicine, and Future Directions in Heart Rhythm Care

Clinical trials and translational research are advancing the understanding, prevention, and treatment of cardiac rhythm disorders. This track explores innovative therapies, precision medicine, new ablation technologies, genetic risk prediction, and evidence-based clinical guidelines. Collaboration between clinicians, researchers, engineers, and technology developers helps translate scientific discoveries into safer, more effective, and individualized heart rhythm care.

• Clinical Trials and Translational Electrophysiology Research
• Precision Medicine, Genetic Risk Prediction, and Personalized Treatment
• Emerging Technologies and Future Directions in Cardiac Rhythm Management

Focus Areas: Clinical Trials in Electrophysiology | Precision Medicine | Translational Cardiac Research | Emerging Rhythm Technologies | Evidence-Based Clinical Guidelines | Novel Ablation Technologies | Genetic Risk Prediction | Personalized Arrhythmia Treatment | Clinical Outcomes Research | Real-World Evidence | Novel Antiarrhythmic Therapies | Artificial Intelligence in Electrophysiology | Long-Term Arrhythmia Outcomes | Multicenter Clinical Studies | Future Innovations in Cardiac Rhythm Management

Participation Benefits and Presentation Categories

Oral Presentation

Oral presentations at Heart Rhythm 2027 welcome research-based, clinical, theoretical, and professional contributions related to cardiac arrhythmias, cardiac electrophysiology, cardiovascular medicine, heart rhythm monitoring, and innovative cardiac care. Researchers, cardiologists, physicians, academicians, and healthcare professionals are encouraged to share their findings, clinical experiences, and advancements.

• Speaker Presentation: Oral presentation followed by a question-and-answer session.
• Keynote Presentation: Expert-led talks highlighting major developments and future directions in heart rhythm research and treatment.

Workshop Presentation

Workshops at Heart Rhythm 2027 provide opportunities for interactive learning, professional knowledge exchange, and discussion of advancements in cardiac rhythm diagnosis and management.

• Clinical techniques and electrophysiology procedures.
• Cardiac device technologies and rhythm-monitoring methods.
• Case discussions, emerging technologies, and innovative treatment approaches.

Poster Presentation

The Poster Presentation session at Heart Rhythm 2027 encourages students, early-career researchers, clinicians, and professionals to showcase original research in cardiac rhythm disorders and cardiovascular medicine.

• Present research findings, clinical studies, and case reports.
• Participate in scientific discussions and answer questions from attendees.
• Gain visibility and exchange knowledge with experts and fellow researchers.

Webinar / Virtual Presentation

For participants who are unable to attend in person, virtual presentation options may provide an alternative way to share research and professional insights remotely, subject to the conference's available participation categories.

• Present research through an approved online format.
• Connect with researchers and healthcare professionals.
• Share scientific findings without travelling to the conference venue.

E-Poster Presentation

E-Poster presentations allow participants to display their research in a digital format, supporting the exchange of scientific knowledge among conference attendees.

• Showcase research findings, clinical studies, and innovative developments.
• Share information on cardiac electrophysiology and cardiovascular healthcare.
• Follow the official conference guidelines for submission and display.

Exhibition – Heart Rhythm 2027

The Exhibition Pavilion provides a platform for organizations to showcase innovations in cardiac electrophysiology, cardiac devices, diagnostic technologies, rhythm monitoring, and cardiovascular healthcare solutions.

Potential exhibitors include:

• Cardiology Hospitals and Heart Centers
• Cardiac Electrophysiology Laboratories
• Medical Device Manufacturers
• Pacemaker and Implantable Device Companies
• Cardiac Monitoring and Diagnostic Companies
• Pharmaceutical and Biotechnology Companies
• Digital Health and Artificial Intelligence Companies
• Universities and Research Institutions
• Healthcare Organizations and Service Providers
• Industry and Business Delegates

The exhibition supports product visibility, professional networking, collaboration, and the exchange of ideas within the global cardiac rhythm community.

Advertisement

Advertising opportunities associated with Heart Rhythm 2027 can help organizations promote their products, services, and research to cardiologists, electrophysiologists, healthcare professionals, researchers, and industry representatives.

Sponsorship

Organizations are invited to explore sponsorship opportunities at Heart Rhythm 2027 to increase brand visibility and connect with professionals in cardiac rhythm management and cardiovascular medicine.

Potential areas of collaboration include medical devices, cardiac monitoring, pharmaceutical innovations, digital health, diagnostic technologies, and clinical research.

Communication Instructions

• Please whitelist the official conference email address to help ensure that conference communications reach your inbox.
• If you do not receive confirmation within 48 hours of registration or inquiry, contact the conference coordinator.
• Check your spam or junk folder before contacting the organizing team.

Group Registration

Group registration arrangements may be available for colleagues, research teams, healthcare institutions, and organizations, subject to the conference's registration policies. Please contact the registration team for details regarding eligibility and applicable rates.

General Inquiries

For information about abstract submission, presentation options, registration, exhibition, advertising, or sponsorship opportunities for Heart Rhythm 2027, please contact the conference organizing team through the official website.

Abstract Submission Guidelines – Heart Rhythm 2027

• Submit abstracts through the official Abstract Submission page.
• Abstracts must be written in English and should follow the conference's official word limit and formatting requirements.
• Submissions are welcome in areas related to Cardiac Arrhythmias, Cardiac Electrophysiology, Atrial Fibrillation, Ventricular Arrhythmias, Catheter Ablation, Cardiac Pacing, Implantable Cardiac Devices, ECG and Rhythm Monitoring, Cardiovascular Diagnostics, Digital Health, and Innovations in Heart Rhythm Management.
• Presenting authors must provide their full name, institutional affiliation, country, phone number, email address, and photograph, as requested in the submission form.
• Co-authors must include their full names and institutional affiliations.
• All submitted abstracts will be reviewed by the Heart Rhythm 2027 Scientific Review Committee.
• Authors of accepted abstracts must complete the required conference registration and payment to confirm their participation.
• Please ensure that all submitted information is accurate, as author details and abstract content may be reproduced in the conference program or related publications.
• Complete your registration through the official conference registration page on the Heart Rhythm 2027 website.

Visa Guidelines – Heart Rhythm 2027

The conference organizing committee does not process or guarantee visa approvals. However, supporting documents may be provided to eligible registered participants, subject to conference policies and applicable requirements, including:

• Letter of Invitation
• Letter of Abstract Acceptance
• Registration Payment Receipt

Official invitation letters are generally provided to participants who have completed the required registration procedures. Participants may be asked to provide supporting details, such as their full name, passport copy, date of birth, residential address, mobile number, and photograph, where required.

Participants are responsible for applying for their visas, meeting the relevant embassy or consulate requirements, and covering visa-related expenses.

For visa assistance and documentation inquiries, please contact the Heart Rhythm 2027 Conference Coordinator through the contact details listed on the official conference website.

Market Analysis

Cardiac Monitoring And Cardiac Rhythm Management Devices Market Summary:

The global cardiac monitoring and cardiac rhythm management devices market size was valued at USD 30.0 billion in 2025 and is projected to grow from USD 31.9 billion in 2026 to USD 49.8 billion by 2033, at a CAGR of 6.5% from 2026 to 2033. The North America cardiac monitoring and cardiac rhythm management devices market held the largest share of 45.6% of the global market in 2025. The market growth is driven by the increasing prevalence of cardiovascular diseases and arrhythmias, the growing aging population, and the rising lifestyle-related risk factors.

Increasing cardiovascular incidence is one of the key factors driving the growth of the cardiac monitoring and cardiac rhythm management industry. According to an Oxford Academic article published in January 2025, the global age-standardized prevalence of cardiovascular disease reaches approximately 7,179 cases per 100,000 people, highlighting the significant and ongoing impact of heart conditions worldwide. Such widespread prevalence means that millions are living with diseases that require careful monitoring and timely intervention to prevent complications. In September 2025, Philips introduced a new telemetry platform featuring the Telemetry Monitor 5500 to streamline cardiac monitoring and reduce non-actionable alarms. The system supports scalable, wearable monitoring, mobile workflows, and up to 30-day post-discharge cardiac tracking through its MCOT service.

Past Conference Report

Conference Overview

Previous editions of the Annual Heart Rhythm Conference have provided a platform for cardiologists, electrophysiologists, researchers, academicians, and healthcare professionals to exchange knowledge and discuss developments in cardiac rhythm management.

Scientific Highlights

The conference series has focused on key areas of cardiovascular medicine, including cardiac arrhythmias, electrophysiology, atrial fibrillation, catheter ablation, cardiac pacing, implantable devices, and advanced rhythm-monitoring technologies.

Knowledge Exchange and Collaboration

Through scientific presentations, expert discussions, and professional networking, the conference series encourages collaboration and the exchange of research findings, clinical experiences, and innovative approaches to heart rhythm care.

Looking Ahead to 2027

Building on the scientific focus of previous editions, the 10th Annual Heart Rhythm Conference 2027 will bring together experts to explore emerging research, technological innovations, and advances in cardiac care.

The conference will take place on May 13–14, 2027, in Rome, Italy, under the theme “Advancing Heart Rhythm Care: Innovation, Technology & Better Outcomes.” It aims to foster scientific exchange and collaboration among professionals working to improve the diagnosis, treatment, and management of cardiac rhythm disorders.